Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 97.83 USD -1.67% Market Closed
Market Cap: 4.7B USD
Have any thoughts about
Axsome Therapeutics Inc?
Write Note

Relative Value

The Relative Value of one AXSM stock under the Base Case scenario is 59.46 USD. Compared to the current market price of 97.83 USD, Axsome Therapeutics Inc is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AXSM Relative Value
Base Case
59.46 USD
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
25
vs Industry
11
Median 3Y
14.6
Median 5Y
0
Industry
2.6
Forward
12.3
vs History
vs Industry
Median 3Y
-13.8
Median 5Y
-16.4
Industry
23
Forward
-16.7
vs History
vs Industry
Median 3Y
-21.5
Median 5Y
-26
Industry
17.8
vs History
vs Industry
Median 3Y
-23.8
Median 5Y
-34.2
Industry
25.4
vs History
19
vs Industry
2
Median 3Y
29.3
Median 5Y
24.2
Industry
2.2
vs History
25
vs Industry
10
Median 3Y
14.1
Median 5Y
0
Industry
2.8
Forward
11.9
vs History
25
vs Industry
11
Median 3Y
15.6
Median 5Y
0
Industry
5.4
vs History
vs Industry
Median 3Y
-13.8
Median 5Y
-16.4
Industry
13.7
Forward
-20.5
vs History
vs Industry
Median 3Y
-13.5
Median 5Y
-15.9
Industry
17.2
Forward
-17.3
vs History
vs Industry
Median 3Y
-20.7
Median 5Y
-24.5
Industry
16.5
vs History
vs Industry
Median 3Y
-20.6
Median 5Y
-24.4
Industry
19.3
vs History
15
vs Industry
5
Median 3Y
21.8
Median 5Y
-89
Industry
2

Multiples Across Competitors

AXSM Competitors Multiples
Axsome Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Axsome Therapeutics Inc
NASDAQ:AXSM
4.7B USD 16 -15.2 -15.2 -14.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
771.1B USD 18.9 92.1 49.5 55.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35.3 24.5 28
US
Johnson & Johnson
NYSE:JNJ
368.9B USD 4.2 25.1 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
249.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.8B CHF 3.6 18.2 10.3 12.2
CH
Novartis AG
SIX:NOVN
179.9B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
157.3B GBP 4.1 31 169.2 253.5
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
US
Axsome Therapeutics Inc
NASDAQ:AXSM
Average P/E: 33.6
Negative Multiple: -15.2
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.1
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35.3
86%
US
Johnson & Johnson
NYSE:JNJ
25.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top